The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAGM.L Regulatory News (AGM)

  • There is currently no data for AGM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

PrimaryBid.com Offer

26 Jan 2021 16:47

RNS Number : 9683M
Applied Graphene Materials PLC
26 January 2021
 

 

EMBARGOED FOR 16:35 ON 26th JANUARY 2021

 

THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF ARTICLE 7 OF THE MARKET ABUSE REGULATION (EU) 596/2014 WHICH FORMS PART OF DOMESTIC LAW PURSUANT TO THE EUROPEAN UNION (WITHDRAWAL) ACT 2018.

THIS ANNOUNCEMENT IS FOR INFORMATIONAL PURPOSES ONLY, AND DOES NOT CONSTITUTE OR FORM PART OF ANY OFFER OR INVITATION TO SELL OR ISSUE, OR ANY SOLICITATION OF AN OFFER TO PURCHASE OR SUBSCRIBE FOR, ANY SECURITIES OF APPLIED GRAPHENE MATERIALS PLC.

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN OR INTO, OR TO ANY PERSON LOCATED OR RESIDENT IN, ANY JURISDICTION WHERE IT IS UNLAWFUL TO RELEASE, PUBLISH OR DISTRIBUTE THIS ANNOUNCEMENT.

THIS ANNOUNCEMENT AMOUNTS TO A FINANCIAL PROMOTION FOR THE PURPOSES OF SECTION 21 OF THE FINANCIAL SERVICES AND MARKETS ACT 2000 ("FSMA") AND HAS BEEN APPROVED BY PRIMARYBID LIMITED WHICH IS AUTHORISED AND REGULATED BY THE FINANCIAL CONDUCT AUTHORITY (FRN 779021).

 

 

 

26th January 2021

 

Applied Graphene Materials PLC ("Applied Graphene Materials" or the "Company")

(LON: AGM)

PrimaryBid.com Offer

 

Applied Graphene Materials (LON: AGM), the producer of speciality graphene nanoplatelet dispersions, is pleased to announce, a conditional offer for subscription via PrimaryBid (the "PrimaryBid Offer") of new ordinary shares of 2p each in the Company ("New Ordinary Shares") at an issue price of 41 pence per New Ordinary Share (the "Issue Price"), being a discount of 39 per cent to the closing mid-price of 67.4 pence per Ordinary Share on 25 January 2021 and 24 per cent to the 30 day volume weighted average price of 54 pence per Ordinary Share. The Company is also conducting (i) a placing of new Ordinary Shares at the Issue Price by way of an accelerated bookbuild process (the "Placing"); and (ii) a subscription for new Ordinary Shares at the Issue Price by certain of the Company's Directors and one of the Company's existing shareholders, as announced on 26th January 2021 (the "Subscription").  

The PrimaryBid Offer, the Placing and the Subscription are conditional on the New Ordinary Shares to be issued pursuant to the PrimaryBid Offer, the Placing and the Subscription being admitted to trading on AIM ("Admission"). Admission of the New Ordinary Shares to be issued pursuant to the PrimaryBid Offer is expected to be take place at 8.00 a.m. on 15 February 2021. The PrimaryBid Offer, which is subject to Shareholder approval in General Meeting on 12th February 2021, will not be completed without the Placing also being completed.

The Company will use the funds raised for ongoing working capital funding, including costs associated with continuing the Company's product and technology development roadmap; to service anticipated growth in customer and product demand; and minor capital expenditure.

PrimaryBid Offer

The Company values its retail investor base and is therefore pleased to provide private and other investors the opportunity to participate in the PrimaryBid Offer by applying exclusively through the www.PrimaryBid.com platform and the PrimaryBid mobile app available on the Apple App Store and Google Play. PrimaryBid does not charge investors any commission for this service.

The PrimaryBid Offer, via the PrimaryBid.com platform, will be open to investors from 4:35 p.m. on 26th January 2021. The PrimaryBid Offer will close at the same time as the Bookbuilding Process is completed. The PrimaryBid Offer may close early if it is oversubscribed.

The Company in consultation with PrimaryBid reserves the right to scale back any order at its discretion. The Company and PrimaryBid reserve the right to reject any application for subscription under the Offer without giving any reason for such rejection.

No commission is charged to investors on applications to participate in the PrimaryBid Offer made through PrimaryBid. It is vital to note that once an application for New Ordinary Shares has been made and accepted via PrimaryBid, an application cannot be withdrawn.

For further information on PrimaryBid.com or the procedure for applications under the PrimaryBid Offer, visit www.PrimaryBid.com or call PrimaryBid.com on +44 20 3026 4750. 

The New Ordinary Shares will be issued free of all liens, charges and encumbrances and will, when issued and fully paid, rank pari passu in all respects with the Company's existing Ordinary Shares.

Applied Graphene Materials PLC

Adrian Potts (Chief Executive Officer), David Blain (Chief Financial Officer)

 

+44 (0) 1642 438 214

PrimaryBid Limited

 James Deal / Charles Spencer

 

+ 44 (0) 203 026 4750

N+1 Singer, Nominated Advisor

Peter Steel, Amanda Gray

 

 

+44 (0) 207 496 3000

The Company highly values its retail investor base which has supported the Company alongside institutional investors over several years. Given the longstanding support of retail shareholders, the Company believes that it is appropriate to provide retail and other interested investors the opportunity to participate in the Offer. The Company is therefore making the Offer available exclusively through PrimaryBid.com.

The Offer is offered under the exemptions against the need for a prospectus allowed under the Prospectus Rules. As such, there is no need for publication of a prospectus pursuant to the Prospectus Rules, or for approval of the same by the Financial Conduct Authority in its capacity as the UK Listing Authority. The Offer is not being made into any Restricted Jurisdiction or any other jurisdiction where it would be unlawful to do so.

There is a minimum subscription of £100 per investor under the terms of the Offer which is open to existing shareholders and other investors subscribing via PrimaryBid.com.

For further details please refer to the PrimaryBid.com website at www.PrimaryBid.com. The terms and conditions on which the Offer is made, including the procedure for application and payment for New Ordinary Shares, is available to all persons who register with PrimaryBid.com.

Investors should make their own investigations into the merits of an investment in the Company. Nothing in this announcement amounts to a recommendation to invest in the Company or amounts to investment, taxation or legal advice.

It should be noted that a subscription for New Ordinary Shares and investment in the Company carries a number of risks. Investors should consider the risk factors set out on PrimaryBid.com before making a decision to subscribe for New Ordinary Shares. Investors should take independent advice from a person experienced in advising on investment in securities such as the New Ordinary Shares if they are in any doubt. 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
OUPBLGDBUSDDGBL
Date   Source Headline
30th Mar 20237:00 amRNSCorrection: Completion of Disposal
29th Mar 20237:00 amRNSCompletion of Disposal
28th Mar 20235:30 pmRNSApplied Graphene Materials
15th Mar 202312:35 pmRNSResult of General Meeting
27th Feb 20234:50 pmRNSPosting of Circular & Notice of General Meeting
22nd Feb 20237:00 amRNSProposed Disposal & Proposed Delisting
1st Feb 20237:30 amRNSSuspension - Applied Graphene Materials plc
26th Jan 20231:50 pmRNSUpdate on Annual Report and Accounts
13th Jan 20237:00 amRNSUpdate on Strategic Review & Other Matters
3rd Jan 20234:40 pmRNSSecond Price Monitoring Extn
3rd Jan 20234:35 pmRNSPrice Monitoring Extension
3rd Jan 20232:05 pmRNSSecond Price Monitoring Extn
3rd Jan 20232:00 pmRNSPrice Monitoring Extension
29th Dec 20224:40 pmRNSSecond Price Monitoring Extn
29th Dec 20224:35 pmRNSPrice Monitoring Extension
28th Dec 20227:00 amRNSStrategic Review Update
23rd Nov 20224:41 pmRNSSecond Price Monitoring Extn
23rd Nov 20224:36 pmRNSPrice Monitoring Extension
23rd Nov 20229:05 amRNSSecond Price Monitoring Extn
23rd Nov 20229:00 amRNSPrice Monitoring Extension
23rd Nov 20227:00 amRNSStrategic Review
22nd Nov 20224:40 pmRNSSecond Price Monitoring Extn
22nd Nov 20224:35 pmRNSPrice Monitoring Extension
22nd Nov 20222:05 pmRNSSecond Price Monitoring Extn
22nd Nov 20222:00 pmRNSPrice Monitoring Extension
9th Nov 202211:06 amRNSSecond Price Monitoring Extn
9th Nov 202211:00 amRNSPrice Monitoring Extension
8th Nov 20222:06 pmRNSSecond Price Monitoring Extn
8th Nov 20222:00 pmRNSPrice Monitoring Extension
8th Nov 20228:09 amRNSUpdate
20th Sep 20224:40 pmRNSSecond Price Monitoring Extn
20th Sep 20224:35 pmRNSPrice Monitoring Extension
14th Sep 20227:00 amRNSAGM Signs Agreement With Major Car Care Brand
30th Aug 20227:40 amEQSApplied Graphene Materials (AGM): Leading innovation with graphene dispersions
17th Aug 20222:06 pmRNSSecond Price Monitoring Extn
17th Aug 20222:00 pmRNSPrice Monitoring Extension
8th Jul 20224:40 pmRNSSecond Price Monitoring Extn
8th Jul 20224:35 pmRNSPrice Monitoring Extension
8th Jul 20223:55 pmRNSUpdate
17th May 20227:00 amRNSExclusive agreement with Indian distributor
3rd May 20227:00 amRNSNew data package for chemical resistant coatings
6th Apr 20227:00 amRNSInterim Results
28th Mar 20227:00 amRNSInvestor Presentation
24th Mar 20227:00 amRNSNotice of interim results
15th Mar 20227:00 amRNSAGM signs agreement with Rayoung Chemtech
7th Feb 20227:00 amRNSAGM to show latest technology at coatings events
3rd Feb 20227:00 amRNSGraphene coating for power transmission assets
31st Jan 20223:54 pmRNSIssue of share options
17th Jan 20227:00 amRNSAGM coatings solutions used for EA flood defence
11th Jan 202211:36 amRNSGrant of Options

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.